These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38644067)

  • 1. Rationale and design of the PACIFIC-PRESERVED (PhenomApping, ClassIFication and Innovation for Cardiac dysfunction in patients with heart failure and PRESERVED left ventricular ejection fraction) study.
    Hulot JS; Janiak P; Boutinaud P; Boutouyrie P; Chézalviel-Guilbert F; Christophe JJ; Cohen A; Damy T; Djadi-Prat J; Firat H; Hervé PY; Isnard R; Jondeau G; Mousseaux E; Pernot M; Prot P; Tyl B; Soulat G; Logeart D;
    Arch Cardiovasc Dis; 2024 May; 117(5):332-342. PubMed ID: 38644067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenomapping for novel classification of heart failure with preserved ejection fraction.
    Shah SJ; Katz DH; Selvaraj S; Burke MA; Yancy CW; Gheorghiade M; Bonow RO; Huang CC; Deo RC
    Circulation; 2015 Jan; 131(3):269-79. PubMed ID: 25398313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the United Kingdom Heart Failure with Preserved Ejection Fraction Registry.
    UK HFpEF Collaborative Group
    Heart; 2024 Feb; 110(5):359-365. PubMed ID: 37827557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic benefit of early diagnosis with exercise stress testing in heart failure with preserved ejection fraction.
    Saito Y; Obokata M; Harada T; Kagami K; Wada N; Okumura Y; Ishii H
    Eur J Prev Cardiol; 2023 Jul; 30(9):902-911. PubMed ID: 37094815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is cardiac resynchronization therapy an option in heart failure patients with preserved ejection fraction? Justification for the ongoing KaRen project.
    Donal E; Lund L; Linde C; Daubert JC;
    Arch Cardiovasc Dis; 2010; 103(6-7):404-10. PubMed ID: 20800804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction.
    Reddy YNV; Andersen MJ; Obokata M; Koepp KE; Kane GC; Melenovsky V; Olson TP; Borlaug BA
    J Am Coll Cardiol; 2017 Jul; 70(2):136-148. PubMed ID: 28683960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of heart failure with preserved ejection fraction : Deep phenotyping for targeted therapeutics.
    Heinzel FR; Shah SJ
    Herz; 2022 Aug; 47(4):308-323. PubMed ID: 35767073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Left Atrial Function on Exercise Capacity and Left Ventricular Function in Patients With Heart Failure and Preserved Ejection Fraction.
    von Roeder M; Rommel KP; Kowallick JT; Blazek S; Besler C; Fengler K; Lotz J; Hasenfuß G; Lücke C; Gutberlet M; Schuler G; Schuster A; Lurz P
    Circ Cardiovasc Imaging; 2017 Apr; 10(4):. PubMed ID: 28360259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure with preserved ejection fraction phenogroup classification using machine learning.
    Kyodo A; Kanaoka K; Keshi A; Nogi M; Nogi K; Ishihara S; Kamon D; Hashimoto Y; Nakada Y; Ueda T; Seno A; Nishida T; Onoue K; Soeda T; Kawakami R; Watanabe M; Nagai T; Anzai T; Saito Y
    ESC Heart Fail; 2023 Jun; 10(3):2019-2030. PubMed ID: 37051638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Cardiovascular Reserve to Prognostic Categories of Heart Failure With Preserved Ejection Fraction: A Classification Based on Machine Learning.
    Przewlocka-Kosmala M; Marwick TH; Dabrowski A; Kosmala W
    J Am Soc Echocardiogr; 2019 May; 32(5):604-615.e6. PubMed ID: 30718020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure with preserved ejection fraction (HFpEF) pathophysiology study (IDENTIFY-HF): does increased arterial stiffness associate with HFpEF, in addition to ageing and vascular effects of comorbidities? Rationale and design.
    Ali D; Callan N; Ennis S; Powell R; McGuire S; McGregor G; Weickert MO; Miller MA; Cappuccio FP; Banerjee P
    BMJ Open; 2019 Nov; 9(11):e027984. PubMed ID: 31748285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and Design of the Multicenter Trial on Japan Working Group on the Effects of Angiotensin Receptor Blockers Selection (Azilsartan vs. Candesartan) on Diastolic Function in the Patients Suffering from Heart Failure with Preserved Ejection Fraction: J-TASTE Trial.
    Takahama H; Asakura M; Abe Y; Ajioka M; Aonuma K; Anzai T; Hayashi T; Hiramitsu S; Kawai H; Kioka H; Kimura K; Lim YJ; Matsuoka K; Motoki H; Nagata Y; Nakamura S; Ohte N; Ozaki Y; Sasaoka T; Tamaki S; Hamasaki T; Kitakaze M;
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):381-388. PubMed ID: 29974299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions.
    Peters AE; Tromp J; Shah SJ; Lam CSP; Lewis GD; Borlaug BA; Sharma K; Pandey A; Sweitzer NK; Kitzman DW; Mentz RJ
    Cardiovasc Res; 2023 Feb; 118(18):3403-3415. PubMed ID: 36448685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure with preserved ejection fraction: Classification based upon phenotype is essential for diagnosis and treatment.
    Xanthopoulos A; Triposkiadis F; Starling RC
    Trends Cardiovasc Med; 2018 Aug; 28(6):392-400. PubMed ID: 29471985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.
    Obokata M; Reddy YNV; Pislaru SV; Melenovsky V; Borlaug BA
    Circulation; 2017 Jul; 136(1):6-19. PubMed ID: 28381470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.